109 related articles for article (PubMed ID: 3372010)
1. Monoclonal antibodies against human recombinant tumor necrosis factor: prevention of endotoxic shock.
Shimamoto Y; Chen RL; Bollon A; Chang A; Khan A
Immunol Lett; 1988 Apr; 17(4):311-7. PubMed ID: 3372010
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
Sheehan KC; Ruddle NH; Schreiber RD
J Immunol; 1989 Jun; 142(11):3884-93. PubMed ID: 2469726
[TBL] [Abstract][Full Text] [Related]
3. The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.
Smith SR; Terminelli C; Kenworthy-Bott L; Calzetta A; Donkin J
J Leukoc Biol; 1994 Jun; 55(6):711-8. PubMed ID: 8195696
[TBL] [Abstract][Full Text] [Related]
4. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
Ashkenazi A; Marsters SA; Capon DJ; Chamow SM; Figari IS; Pennica D; Goeddel DV; Palladino MA; Smith DH
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10535-9. PubMed ID: 1660140
[TBL] [Abstract][Full Text] [Related]
5. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha).
McLaughlin PJ; Elwood NJ; Russell SM; Andrew SM; McKenzie IF
Anticancer Res; 1992; 12(4):1243-6. PubMed ID: 1503416
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of monoclonal antibodies against recombinant human tumor necrosis factor alpha.
Li Y; Zhao WW; Shen BF; Sun YX; Wang WX
Chin J Biotechnol; 1991; 7(2):121-6. PubMed ID: 1806022
[TBL] [Abstract][Full Text] [Related]
7. Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody.
Jin H; Yang R; Marsters SA; Bunting SA; Wurm FM; Chamow SM; Ashkenazi A
J Infect Dis; 1994 Nov; 170(5):1323-6. PubMed ID: 7963738
[TBL] [Abstract][Full Text] [Related]
8. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock.
Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P
Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827
[TBL] [Abstract][Full Text] [Related]
9. Four epitopes on tumor necrosis factor-alpha defined by murine anti-tumor necrosis factor-alpha monoclonal antibodies.
Karim B; Béliard R; Huart JJ; Bourel D
Immunol Lett; 1994 Jul; 41(2-3):139-45. PubMed ID: 8002029
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lipid A- and lipopolysaccharide-induced cytokine secretion, B cell mitogenesis, and lethal shock by lipid A-specific murine monoclonal antibodies.
Ramachandra RN; Berczi A; Sehon AH; Berczi I
J Infect Dis; 1993 May; 167(5):1151-9. PubMed ID: 8486948
[TBL] [Abstract][Full Text] [Related]
11. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production.
Greeneltch KM; Haudenschild CC; Keegan AD; Shi Y
Brain Behav Immun; 2004 Sep; 18(5):476-84. PubMed ID: 15265541
[TBL] [Abstract][Full Text] [Related]
12. Detection and neutralization of bovine tumor necrosis factor by a monoclonal antibody.
Sileghem M; Saya R; Ellis JA; Flynn JN; Peel JE; Williams DJ
Hybridoma; 1992 Oct; 11(5):617-27. PubMed ID: 1459585
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to human tumor necrosis factor alpha: in vitro and in vivo application.
Möller A; Emling F; Blohm D; Schlick E; Schollmeier K
Cytokine; 1990 May; 2(3):162-9. PubMed ID: 1716486
[TBL] [Abstract][Full Text] [Related]
14. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
[TBL] [Abstract][Full Text] [Related]
15. ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock.
Conrad U; Plagmann I; Malchow S; Sack M; Floss DM; Kruglov AA; Nedospasov SA; Rose-John S; Scheller J
Plant Biotechnol J; 2011 Jan; 9(1):22-31. PubMed ID: 20444206
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-tumor necrosis factor (TNF) antibodies protect mouse and human cells from TNF cytotoxicity.
Galloway CJ; Madanat MS; Mitra G
J Immunol Methods; 1991 Jun; 140(1):37-43. PubMed ID: 2061612
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
Marchant A; Bruyns C; Vandenabeele P; Ducarme M; Gérard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
Wysocka M; Kubin M; Vieira LQ; Ozmen L; Garotta G; Scott P; Trinchieri G
Eur J Immunol; 1995 Mar; 25(3):672-6. PubMed ID: 7705395
[TBL] [Abstract][Full Text] [Related]
20. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody.
Corti A; Bagnasco L; Cassani G
Lymphokine Cytokine Res; 1994 Jun; 13(3):183-90. PubMed ID: 7524695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
